Research graph
References from Treatment and Outcomes of Kawasaki Disease Over 40 Years. Local targets link to admitted publications; unresolved targets remain external evidence.
JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease
10.1253/circj.cj-19-1094 · 2020 · External reference
Kawasaki syndrome
10.1016/s0140-6736(04)16814-1 · 2004 · External reference
Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association
10.1161/cir.0000000000001295 · 2024 · External reference
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association
10.1161/cir.0000000000000484 · 2017 · External reference
Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis
10.1136/archdischild-2023-325639 · 2023 · External reference
Anakinra treatment in patients with acute Kawasaki disease with coronary artery aneurysms: a phase I/IIa trial
10.1016/j.jpeds.2021.12.035 · 2022 · External reference
Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis
10.3389/fcvm.2023.1164530 · 2023 · External reference
Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population
10.1161/jaha.118.011319 · 2019 · External reference
Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19
10.1007/s11886-021-01602-3 · 2021 · External reference
Council of State and Territorial Epidemiologists/CDC Surveillance case definition for multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection - United States
10.15585/mmwr.rr7104a1 · 2022 · External reference
Unresolved reference
2021 · External reference
Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography
10.1016/j.echo.2018.06.004 · 2019 · External reference
Guidelines for performing a comprehensive pediatric transthoracic echocardiogram: recommendations from the American Society of Echocardiography
10.1016/j.echo.2023.11.015 · 2024 · External reference
New equations and a critical appraisal of coronary artery Z scores in healthy children
10.1016/j.echo.2010.10.004 · 2011 · External reference
Coronary artery diameter can be assessed reliably with transthoracic echocardiography
10.1152/ajpheart.00819.2003 · 2004 · External reference
Intravenous immunoglobulin for the treatment of Kawasaki disease
2023 · External reference
Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011–2016): KAWA-RACE study group
10.1371/journal.pone.0215665 · 2019 · External reference
Epidemiology of Kawasaki disease in Asia, Europe, and the United States
10.2188/jea.je20110131 · 2012 · External reference
The treatment of Kawasaki syndrome with intravenous gamma globulin
10.1056/nejm198608073150601 · 1986 · External reference
Clinical presentation and outcomes of Kawasaki disease in children from Latin America: a multicenter observational study from the REKAMLATINA Network
10.1016/j.jpeds.2023.02.001 · 2023 · External reference
Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population
10.1161/jaha.116.003289 · 2016 · External reference
Outcome of coronary artery aneurysms after Kawasaki disease
10.1016/s0022-3476(05)81894-3 · 1992 · External reference
Analysis of coronary arterial aneurysm regression in patients with Kawasaki disease by aneurysm severity: factors associated with regression
10.1161/jaha.121.022417 · 2023 · External reference
Long-term outcome of coronary abnormalities in patients after Kawasaki disease
10.1007/bf02505086 · 1996 · External reference
Pathological alterations of coronary arteries late after Kawasaki disease: an optical coherence tomography study
10.1016/j.jacadv.2024.100937 · 2024 · External reference
Association of initially normal coronary arteries with normal findings on follow-up echocardiography in patients with Kawasaki disease
10.1001/jamapediatrics.2018.3310 · 2018 · External reference
Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment
10.1179/1465328111y.0000000005 · 2011 · External reference
Treatment and coronary artery aneurysm formation in Kawasaki disease: a per-day risk analysis
10.1016/j.jpeds.2021.12.054 · 2022 · External reference
Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study
10.4070/kcj.2016.46.4.550 · 2016 · External reference
Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease
10.1136/archdischild-2018-314967 · 2019 · External reference
Risk factors of coronary artery aneurysms in Kawasaki disease with a low risk of intravenous immunoglobulin resistance: an analysis of Post RAISE
10.1016/j.jpeds.2021.08.065 · 2022 · External reference
Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis
10.1371/journal.pone.0248812 · 2021 · External reference
Pericardial effusion in children admitted with Kawasaki disease: a multicenter retrospective cohort study from the Pediatric Health Information System
10.1177/0009922820927021 · 2021 · External reference
Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
2023 · External reference
A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children
10.1016/j.ppedcard.2022.101516 · 2022 · External reference
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases
10.1016/j.rdc.2023.03.002 · 2023 · External reference
Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin
10.1016/j.ijcard.2016.03.017 · 2016 · External reference
Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease
10.1002/art.39975 · 2017 · External reference
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease
10.1161/circulationaha.111.072769 · 2012 · External reference
Phase II open label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease
10.1002/art.41481 · 2021 · External reference
Anakinra for treatment-resistant Kawasaki disease: evidence from a literature review
10.1007/s40272-020-00421-3 · 2020 · External reference
